Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2013; 19(3): 366-374
Published online Jan 21, 2013. doi: 10.3748/wjg.v19.i3.366
Figure 2
Figure 2 Overall survival curves of surgical resection and transarterial chemoembolization in patients with liver cirrhosis. Among patients with cirrhosis, the overall survival (OS) rates were not different between the surgical resection group and the transarterial chemoembolization (TACE) group (25.5% vs 24.7% 5-year OS rate, P = 0.225).